The Efficacy Profiles of Concurrent Chemoradiotherapy with Intensity-Modulated Radiotherapy Followed by Durvalumab in Patients with Unresectable Stage III Non–small Cell Lung Cancer: A Multicenter Retrospective Cohort Study

Yuichiro Takeda,Yusaku Kusaba,Yoko Tsukita,Yukari Uemura,Eisaku Miyauchi,Takaya Yamamoto,Hiroshi Mayahara,Akito Hata,Hidetsugu Nakayama,Satoshi Tanaka,Junji Uchida,Kazuhiro Usui,Tatsuya Toyoda,Motohiro Tamiya,Masahiro Morimoto,Yuko Oya,Takeshi Kodaira,Keiichi Jingu,Hisatoshi Sugiura

Clinical and Translational Radiation Oncology（2022）

Cited 1|Views27

Key words

Concurrent chemoradiotherapy,Durvalumab consolidation,Intensity-modulated radiotherapy,Landmark analysis,Non-small cell lung cancer,Multivariate analysis

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined